⌘K

Login Start Free

Home/Filings/4/0001079973-10-001265

4//SEC Filing

BROVARONE DENNIS 4

Accession 0001079973-10-001265

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:30 PM ET

Size

14.6 KB

Accession

0001079973-10-001265

Insider Transaction Report

Form 4

Period: 2010-12-01

PURE BIOSCIENCEPURE

BROVARONE DENNIS

Director

Transactions

Exercise/Conversion
Common Stock
2010-12-02$0.53/sh+1,100$583→ 255,141 total
Exercise/Conversion
Common Stock
2010-12-01$0.53/sh+8,900$4,717→ 255,141 total
Exercise/Conversion
Stock Option
2010-12-02−1,100→ 0 total
Exercise: $0.53From: 2004-12-21Exp: 2011-01-07→ Common Stock (1,100 underlying)
Sale
Common Stock
2010-12-02$2.17/sh−1,100$2,388→ 255,141 total
Sale
Common Stock
2010-12-01$2.15/sh−8,900$19,091→ 255,141 total
Exercise/Conversion
Stock Option
2010-12-01−8,900→ 1,100 total
Exercise: $0.53From: 2004-12-21Exp: 2011-01-07→ Common Stock (8,900 underlying)

Footnotes (3)

[F1]Transactions pursuant to Rule 10B5-1 Plan.
[F2]Incorporates all transactions being reported on this form.
[F3]Granted pursuant to 2001 Directors and Officers Stock Option Plan

Documents

1 file

4
pure_brovarone4.xmlPrimary

Issuer

PURE BIOSCIENCE

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001053769

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 4:30 PM ET
Size: 14.6 KB

View on SEC.gov